Nathalie Dhomen

5.9k citations
34 papers · 3.2k indexed · 1 hit paper · h-index 19

Nathalie Dhomen

34 papers receiving 3.2k citations

Hit Papers

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tum...1.1k20102026201520202505007501000

Peers

Nathalie Dhomen
Comparison fields: 5 of 99
  • Oncology 1.6k
  • Cancer Research 585
  • Molecular Biology 2.2k
  • Immunology 474
  • Pathology and Forensic Medicine 375
Replace María Romina Girotti with:
María Romina Girotti Argentina
Amaya Virós United Kingdom
Patricia Brafford United States
Therese M. Becker Australia
David Dankort Canada
Antonella Bacchiocchi United States
Deric L. Wheeler United States
Chiara Ambrogio United States
Lawrence N. Kwong United States
Ethan V. Abel United States
Nathalie Dhomen relative to María Romina Girotti Argentina María Romina Girotti's profile →
Citations per field
00.5×1.7×
María Romina Girotti · 1×
Citations per year

Countries citing papers authored by Nathalie Dhomen

Since Specialization
Citations

This map shows the geographic impact of Nathalie Dhomen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Dhomen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Dhomen more than expected).

Fields of papers citing papers by Nathalie Dhomen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Dhomen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Dhomen. The network helps show where Nathalie Dhomen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nathalie Dhomen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nathalie Dhomen Line = papers co-authored together Nathalie Dhomen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20226
2 2020144
3 20203
4 20203
5 201875
6 2017123
7 2017116
8 201773
9 20171
10 201646
11 201627
12 2015131
13 2014171
14 2014164
15 201060
16 2009147
17 200918
18 2009408
19 20088
20 2007204

About Nathalie Dhomen

Nathalie Dhomen is a scholar working on Oncology, Cancer Research and Cell Biology, having authored 34 papers that have together received 3.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (14 papers), Cutaneous Melanoma Detection and Management (8 papers), Cancer Genomics and Diagnostics (7 papers), melanin and skin pigmentation (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Retinal Development and Disorders (3 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (585 citations) and Molecular Biology (2.2k citations). Nathalie Dhomen has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Richard Marais, Jorge S. Reis‐Filho, Catrin Pritchard, Carla Milagre, Caroline J. Springer, Jahan Hussain, Steven R. Whittaker, Arnaud Nourry, Robert Hayward and Lionel Larue.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026